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ABSTRACT 
Purpose: This exploratory study aimed to examine emotion-processing styles in patients with 
psychogenic non-epileptic seizures (PNES), compared to healthy individuals, and to explore 
associations of emotion processing with other psychological measures and seizure frequency, using 
the new Emotional Processing Scale (EPS-25), which had not previously been used in this patient 
group.  
Methods: Fifty consecutive patients with PNES referred for psychotherapy completed a set of self-
report questionnaires, including the Emotional Processing Scale (EPS-25), Clinical Outcome in 
Routine Evaluation (CORE-10), Short Form–36 (SF-36), Patient Health Questionnaire (PHQ-15), and 
Brief Illness Perception Questionnaire (BIPQ). Responses on the EPS-25 were compared to data from 
224 healthy controls.  
Results: Patients with PNES had greater emotion processing deficits across all dimensions of the EPS-
25 than healthy individuals (suppression / unprocessed emotion / unregulated emotion / avoidance 
/ impoverished emotional experience). Impaired emotion processing was highly correlated with 
psychological distress, more frequent and severe somatic symptoms, and a more threatening 
understanding of the symptoms. Emotion processing problems were also associated with reduced 
health-related quality of life on the mental health (but not the physical health) component of the SF-
36. The unregulated emotions sub-scale of the EPS was associated with lower seizure frequency.  
Conclusion: The results showed clear impairments of emotion processing in patients with PNES 
compared to healthy individuals, which were associated with greater psychological distress and 
reduced mental health functioning. These findings seem to support the face validity of the EPS-25 as 
a measure for PNES patients and its potential as a tool to assess the effectiveness of psychological 
interventions. 
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INTRODUCTION 
Psychogenic non-epileptic seizures (PNES) are episodes of alteration of consciousness and 
disturbance of sensory, motor, autonomic or cognitive functions that superficially resemble epileptic 
seizures. They are not caused by abnormal electrical discharges in the brain but are thought to 
represent an experiential and behavioural response to psychological distress perceived by patients 
as involuntary [1]. Most fulfil the diagnostic criteria of a conversion or somatic symptom disorder in 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [2] or of dissociative convulsions 
in the International Classification of Diseases (ICD-10) [3].  
Within the current bio-psycho-social model, PNES are explained as resulting from the interaction of 
multiple predisposing, precipitating and perpetuating factors, including a dysfunctional family 
environment, childhood abuse or other traumatic experiences [1]. The association with early life 
adversity and traumatic experiences means that PNES could be linked to abnormal emotion 
processing [4]. Emotion processing can broadly be defined as the way in which individuals process 
and absorb emotional disturbances associated with adverse life events [5, 6]. Emotion processing is 
multifaceted, and there has been considerable ambiguity in the conceptualisation of its association 
to related constructs such as emotion regulation, emotion expressiveness, emotion intelligence, 
emotion control or alexithymia [7, 8]. In particular, there seems to be an overlap between the 
concepts of emotion regulation, described as “the processes responsible for the monitoring, 
evaluating, and modifying of emotional reactions to accomplish one’s goals” [9], alexithymia or 
difficulties in understanding and expressing emotions [10] and emotion processing.  
Baker et al. [7] developed a model of emotion processing which integrates the different emotion-
related concepts. According to this model, emotion processing consists of an input in the form of an 
event that is consciously or unconsciously registered, followed by rapid and unconscious appraisal of 
the event and subsequent emotional experience, which is central to the processing of emotion and 
includes awareness of emotions, experiencing emotions as psychological wholes, identifying and 
labelling of emotions and linking them to relevant causal events. The final output stage is an 
appropriate expression of emotions. Incomplete processing characterised by prolonged or excessive 
avoidance and/or inhibition of negative emotions can result in intrusive or obsessive thoughts, 
disturbances of behaviour and experience, and further prevents the integration and resolution of 
negative emotional experiences [7, 11]. Abnormal emotion processing has been associated with the 
development and maintenance of a number of psychological disorders, including Posttraumatic 
Stress Disorder [12], panic [6], depression [13] and psychosomatic conditions [14], such as 
fibromyalgia [15], chronic fatigue syndrome [16] and chronic pain [17]. 
An adapted form of this model has been applied to PNES, suggesting that PNES might actually be 
conceptualised as manifestations of abnormal emotion processing [11]. A number of experimental 
and self-report studies have investigated different concepts related to emotion processing in PNES 
and described abnormalities in relation to healthy controls, patients with epilepsy or healthy 
controls with a history of trauma [4, 18-22]. As PNES are characterised by a heterogeneous aetiology 
and comorbid psychopathology, the studies have also explored the possibility that there may be 
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several clinically distinct subpopulations of patients with PNES using cluster analysis [4, 20, 21]. The 
results suggest that there may be at least two clusters of PNES patients characterised by higher or 
lower levels of emotion dysregulation and higher or lower levels of abnormality in terms of 
psychopathology or personality profiles. These studies indicate that, while levels of emotion 
dysregulation may be higher in PNES than in the healthy population, the nature and extent of 
emotion dysregulation may depend on interactions with other psychological factors present in the 
disorder.  
“Alexithymia” is one particular emotion-processing problem, which has been studied more 
extensively in patients with PNES: A recent study has found a 36.9% prevalence of alexithymia in 
patients with PNES. Alexithymia was associated with symptoms of psychological trauma, including 
intrusive experiences and defensive avoidance, and cynicism [23]. This corresponds with earlier 
findings of Tojek et al. who reported high alexithymia scores in approximately 30% of patients with 
PNES [24]. Bewley et al. found considerably higher levels of alexithymia in patients with PNES 
(90.5%); however, levels of alexithymia in that study did not differentiate between patients with 
PNES, patients with epilepsy and healthy controls when co-morbid anxiety and depression were 
accounted for [10].  
Another specific aspect of emotion processing which has received particular attention in patients 
with PNES is avoidance (including avoidance of emotions). Several self-report and experimental 
studies have revealed evidence of increased levels of avoidance in patients with PNES and have 
demonstrated a positive correlation between avoidance and PNES frequency and a negative 
correlation between avoidance and Health Related Quality of Life (HRQoL) [25-29].   
Given that PNES can be interpreted as an externalised form of abnormal emotion processing, there 
is a clear need for further research that would shed more light on emotion generation, perception, 
regulation and expression processes in patients with PNES as well as the interaction of emotion 
processing problems with other psychological factors. This exploratory study therefore aims to 
describe emotion processing styles of patients with PNES compared to healthy individuals, using the 
new Emotional Processing Scale (EPS-25) [30] developed on the basis of the integrative model of 
emotion processing described above, encompassing a broader range of different emotional 
processing deficits than other emotion scales. As a secondary aim, this study sought to explore the 
clinical utility of the EPS-25 as a measure to assess patients with PNES in the planning stage of 
therapeutic interventions or as a process measure before and after treatment.  
METHODS 
Subjects 
Patients with PNES were recruited consecutively from those referred to the Neurology 
Psychotherapy Service at the Royal Hallamshire Hospital and Barnsley Hospital for psychotherapy. 
All patients had been diagnosed by experienced Consultant Neurologists with a specialist interest in 
seizure disorder based at the Sheffield Teaching Hospitals NHS Foundation Trust on the basis of all 
clinical information available (including video-EEG recordings of typical events in most cases). All 
patients provided written informed consent.  
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Demographic and Emotional Processing Scale (EPS-25) data from 224 healthy controls provided by 
the developers of the EPS were used for comparison [30, 31]. The healthy controls were recruited 
from a range of community sources and workplaces. They were matched in age and gender with the 
PNES group.  
Design and Procedure 
This is a prospective, cross-sectional study. The study has been approved by the Sheffield Local 
Research Ethics Committee on 1st May 2009. The study was undertaken at the Sheffield Teaching 
Hospitals NHS Foundation Trust Department of Neurology. 
Information concerning the study was sent to patients when they were invited in for their initial 
assessment session with a psychotherapist. In the assessment session, patients were screened for 
serious psychiatric conditions, suicide risk and suitability for psychotherapy, the diagnosis of PNES 
was further explained, and they were introduced to a range of self-help strategies.  They were also 
given another copy of the patient information form and invited to join the study at the end of the 
assessment session. Written informed consent was taken at this point. Patients who agreed to take 
part were asked to complete a set of self-report measures after this initial session but before their 
first therapy session (approximately three months after the initial assessment).  
Measures 
Demographic and referral questionnaires 
Demographic and clinical information was collected on questionnaires completed by patients and 
the referring neurologists. The frequency of PNES was calculated as the number of attacks per 
month. In addition, given the non-normal distribution of the data, seizure frequency was further 
examined by categorising the data into four categories: (1) more than one seizure per year but less 
than one seizure per month, (2) more than one seizure per month but less than one seizure per 
week, (3) more than one seizure per week but less than one seizure per day, (4) more than one 
seizure per day but less than one seizure per hour, (5) more than one seizure per hour. 
 
Clinical Outcome in Routine Evaluation (CORE-10) 
The CORE-10 is a brief self-report questionnaire measuring global psychological distress, using ten 
items drawn from the 34-item CORE-OM (Outcome Measure) [32]. Each item is scored on a five-
point scale ranging from 0 to 4 with higher scores indicating a greater level of distress. The CORE-OM 
has been validated in large clinical and non-clinical samples and correlates closely with different 
measures of psychological distress, including Beck Depression Inventory [33] and Beck Anxiety 
Inventory [34].  
Response values of the ten items were added to produce a total clinical score (α = .915). For subjects 
with one item missing, the total score was computed as a mean of the completed items multiplied 
by the number of all items, as suggested by the user manual. Subjects with more than one item 
missing were excluded from the analyses (N = 2). 
Short form-36 (SF-36) 
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The SF-36 is a 36-item self-report questionnaire providing one multi-item scale measure of eight 
areas of HRQoL: physical functioning, role limitation - physical, bodily pain, general health, vitality, 
social functioning, role limitation – emotional, and mental health. Items are scored on scales offering 
two to six answers. 
Missing data were replaced by the mean of the completed data in the sub-scale, as recommended 
by the user manual [35]. Subjects with more than a half of the items on any sub-scale missing were 
excluded from the analyses (N = 1). The scores on the eight sub-scales were re-coded, standardised 
using norm-based scoring and combined into physical (PHS, α = .797) and mental (MHS, α = .780) 
health scales, following a previously described procedure [35, 36]. 
Patient Health Questionnaire (PHQ-15)  
The PHQ-15 comprises 15 physical symptoms, extracted from the Patient Health Questionnaire, 
which forms part of the self-administered PRIME-ED diagnostic instrument for common mental 
disorders [37]. Symptoms over the last four weeks are rated on a three-point scale as 0 (‘not 
bothered at all’), 1 (‘bothered a little’) or 2 (‘bothered a lot’) [38]. 
A total score is calculated as a sum of scores on the 15 items of the PHQ-15. There was a 
considerable number of missing data on item 4 in our sample (N missing = 11), addressing menstrual 
problems and item 11 (N missing = 6), addressing problems with sexual intercourse. As these 
questions may not have been applicable to a proportion of participants, the items were excluded. 
For the remaining 13 items, two or fewer missing data per subject were replaced by median scores 
(resulting total score α = .849).  
Brief Illness Perception Questionnaire (BIPQ) 
The BIPQ is a nine-item scale designed to assess the cognitive and emotional representations of 
illness. The nine items represent dimensions of illness perceptions including consequences, timeline, 
personal control, treatment control, identity, illness concern, coherence, emotional representation 
and perceived causes [39]. All items apart from item 9, which is an open-ended question, are scored 
on an eleven-point scale, ranging from 0 to 10.  
The relevant items of the scale were reverse-coded and the eight items were added to produce total 
score representing the degree to which the condition is perceived as threatening (α = .732). For 
subjects with one item missing, the total score was computed as a mean of the completed items 
multiplied by the number of all items, as recommended by the scoring instructions. Subjects with 
more than one item missing were excluded from the analyses (N = 3). 
Emotional Processing Scale (EPS-25) 
The 25-item EPS is a self-administered questionnaire developed to identify and quantify different 
emotional processing styles and deficits [30, 31]. The scale has been derived from the 38-item EPS 
[7]. The EPS-25 contains five subscales: suppression, signs of unprocessed emotion, unregulated 
emotion, avoidance and impoverished emotional experience and it has been shown to have 
satisfactory reliability, test-retest reliability and to correlate well with the Toronto Alexithymia Scale 
(TAS-20) and the Courtauld Emotional Control Scale [7]. 
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Responses of the PNES group to individual questions were combined into the five sub-scales and 
assessed for internal consistency reliability. The reliability of the subscales was acceptable to 
excellent (suppression α = .940, unprocessed emotion α = .926, unregulated emotion α = .746, 
avoidance α = .772 and impoverished emotional experience α = .865). The five sub-scales were 
combined into a total score (α = .921). Missing data on one item was replaced by the mean of the 
completed data in the sub-scale, as recommended in the Administrator’s manual of the EPS [7, 31]. 
Subjects with more than one item missing were excluded from the analysis (N = 1).  
Statistical analyses 
Data were analysed using SPSS (version 19; SPSS Inc., Chicago, IL, U.S.A.). The Shapiro-Wilk test was 
carried out to assess the normality of the distribution of the data. The distributions of the scores on 
PHQ-15, MHC and PHS scale of the SF-36 as well as the compound EPS were found not to be normal. 
In view of this, non-parametric Spearman's correlational analyses were performed to examine 
possible relationships between emotional processing and the other self-report measures in the PNES 
group. To consider differences in emotional processing between the PNES patient group and healthy 
controls, Mann-Whitney U-Tests were performed.  
In view of the fact that this is an exploratory study, no adjustments were made for multiple 
comparisons. Two-sided p-values of <0.05 were considered statistically significant. 
RESULTS 
Subjects 
Of 55 patients with PNES recruited to this study, 50 (14% male) returned a complete set of 
questionnaires and were included in the analyses. Their responses on the EPS were compared to 
those from 224 (13.8% male) healthy controls. Subjects in the PNES group ranged in age from 17 – 
74 years (median = 39, interquartile range = 24.00). The group of healthy controls ranged from 17 – 
78 years (median = 32, interquartile range = 22.00). There was no significant difference in age or 
gender distribution between the two groups (p > .05).  
Comparison of the PNES and healthy control groups 
Comparisons of the measure of emotional processing (EPS) were made between patients with PNES 
(N = 49) and the healthy control group (N = 224).  
The Mann-Whitney U-Test showed that the total EPS scores as well as all of the scores on the EPS 
sub-scales were significantly higher in the PNES group than in the healthy control group (Figure 1).  
----------------------------------------------Insert Figure 1 here---------------------------------------------- 
Correlational analyses within the PNES group 
Examination of the associations between the individual EPS subscales using Spearman’s correlation 
showed significant positive moderate to high relationships between all of the EPS sub-scales (Table 
1). 
----------------------------------------------Insert Table 1 here---------------------------------------------- 
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The relationships between seizure frequency and the EPS scores are detailed in Table 2. Only one 
subject fell in the categories ‘more than one seizure per year but less than one seizure per month’ 
and ‘more than one seizure per hour’. These two extreme cases were excluded as outliers. 
----------------------------------------------Insert Table 2 here---------------------------------------------- 
The differences in EPS scores between the remaining three seizure frequency categories were 
assessed using Kruskal-Wallis test. The only significant difference was found in the unregulated 
emotion sub-scale (X2 = 6.04, p = .049).     
Table 3 provides information about the scores of the 50 patients in the PNES group on the other self-
report measures used in this study.  
----------------------------------------------Insert Table 3 here---------------------------------------------- 
Given that all of the EPS sub-scales were significantly correlated with each other and with the total 
score, the associations of the EPS with the other self-report measures are only reported for the 
compound EPS score. Spearman’s correlation showed a significant positive relationship between the 
compound EPS score (higher scores signify more dysfunctional emotion processing) and somatic 
symptoms as measured by the PHQ-15. The EPS was also correlated positively with psychological 
distress as measured by the CORE-10, and overall illness perceptions as measured by the BIPQ 
(reflecting a more threatening view of the illness).  
There was a strongly negative correlation between the EPS and the Mental Health Scale but not the 
Physical Health Scale of the health-related quality of life measure (SF-36) (lower values on the SF-36 
sub-scales indicate lower quality of life). For correlation coefficients see Table 4. 
----------------------------------------------Insert Table 4 here---------------------------------------------- 
The patients with the lowest EPS scores in this study reported very low psychological distress, 
demonstrating their lack of insight into the aetiology of their seizures. All the patients were 
subsequently seen for psychotherapy by one of the authors (SH) who experienced most of this group 
as emotionally ‘flat’ and inaccessible rather than emotionally healthy.  Indeed, the Administrator’s 
Manual of the EPS [31] highlights that while high scores clearly indicate emotional processing deficits, 
significantly low scores should not imply healthy functioning, but may represent a poor 
understanding of one’s emotional life. While there was no obvious single factor uniting this group, 
three of the ten lowest scorers were wheelchair-bound and seemed to have settled into a life of 
disability and dependence. Three of the group had suffered from frequent accidents affecting their 
mobility and periods of hospitalisation as children, which resulted in them receiving extra attention 
from their parents. In two of these cases PNES started immediately after their mobility had been 
restored. This may be an area that warrants further study. 
DISCUSSION 
This study was intended to increase our understanding of emotion processing in PNES patients using 
the EPS-25, a five-factor measure, which has been validated in patients with a range of physical 
health problems, mental health problems, and patients suffering from pain, including fibromyalgia, 
rheumatoid arthritis and chronic lower back pain [30] but has not previously been used in patients 
with PNES. This study showed that, compared to healthy individuals, people with PNES have greater 
deficits in all five dimensions of emotional processing described by the EPS. This indicates that, as a 
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group, patients with PNES have a strong tendency to suppress emotions and avoid situations that 
may evoke them. However, despite their best efforts, they experience emotions as overwhelming 
and uncontrollable at times. This suggests that it may be the fear of intolerable emotions that 
underlies the tendency to avoid experiencing and processing them, and conversely, that emotions 
that are not faced, recognised and processed may build up until they are uncontrollable. This is in 
keeping with the abnormal patterns of emotional experience and expression found by Roberts et al. 
as well as with the clinical experience of practitioners offering psychological treatment of PNES and 
previous studies demonstrating the importance of avoidance in this patient group [25-28]. 
Impaired emotion processing was highly correlated with greater levels of psychological distress 
measured by the CORE-10. This could reflect a reciprocally causative and reinforcing relationship 
between the two, whereby people experiencing high levels of emotional distress are more likely to 
have a tendency to avoid painful emotions, but therefore never develop the ability to alleviate the 
distress by processing their feelings.  
The examination of the relationship between the EPS and the PHQ-15 showed that the impaired 
emotion processing in the PNES group was also associated with more severe somatic symptoms. In 
superficial contrast with this finding, deficits in emotion processing were associated with reduced 
HRQoL as measured by the mental health component but not the physical health component of the 
SF-36, i.e. subjects felt it was emotional rather than physical factors that impinged on their quality of 
life. This finding is in keeping with previous studies showing an association between emotional 
avoidance and reduced HRQoL [29].  
The discrepancy between the correlation of impaired emotion processing with somatic symptoms 
and the lack of correlation with physical functioning could stem from the different types of physical 
difficulties that these two scales capture. While the PHQ-15 assesses more stress-related or 
autonomic symptoms such as pounding heart, tiredness, dizziness or pain that may be highly 
relevant to the experience of PNES, the physical functioning measured by the SF-36 is more focussed 
on mobility and physical activities such as walking, bending or bathing, which may not be the main 
source of disability in PNES patients. Patients with PNES may be more affected by subjective physical 
symptoms and by the emotional issues relating to their seizures than the absolute limitations of 
physical functioning they may cause.  
Although emotion-processing problems were associated with a more threatening and pessimistic 
understanding of the symptoms as measured by the BIPQ, self-reported emotion processing deficits 
were not related to greater seizure frequency. Conversely, the unregulated emotions sub-scale of 
the EPS was associated with lower frequency of PNES. Unregulated emotions refers to the presence 
of powerful emotional feelings ‘e.g. I felt the urge to smash something’ and how much control is felt 
over the feelings. E.g. ‘I reacted too much to what people said or did’. It is connected to problems in 
emotional expression. Those with the lowest frequency of seizures have a poorer (higher) EPS score, 
i.e. they have more powerful feelings, which they do not feel in control of. Conversely those with 
most seizures feel more control.  This may suggest seizures operate as a method of dealing with 
powerful emotions and give the person a sense of greater control. This finding resonates with the 
results of a study by Dimaro et al., which compared explicit and implicit anxiety and self-esteem in 
patients with PNES, those with epilepsy and healthy controls [25]. Dimaro et al. found discrepancies 
between explicit and implicit anxiety and self-esteem measures in the PNES but not the other two 
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participant groups. They interpreted their findings as indicating that PNES may serve a protective 
function: whilst patients with PNES (explicitly) self-reported high levels of anxiety and low levels self-
esteem, the Implicit Relational Assessment Procedure (IRAP) measures suggested that their self-
image was not characterised by elevated anxiety or reduced self-esteem [25, 40]. 
Limitations 
The cross-sectional design of this study means that it is not possible to draw any conclusive 
inferences about causality from the associations identified. There is a need for prospective studies to 
explore the associations further and to assess the sensitivity of this measure to change in this 
patient group.   
There are limitations associated with the use of self-report measures, which can only measure 
explicitly recognised experiences rather than unconscious implicit experiences, which are not 
accessible to self-report. Discrepancies between explicit and implicit emotion awareness may well 
be particularly relevant in this patient group experiencing extreme abnormalities of emotional 
processing [11, 25].    
PNES are a very heterogeneous disorder and it is possible that some of our unexpected findings are 
accounted for by a subgroup of PNES patients in this study who scored very low on the EPS. Low 
scores could be consistent with very good emotional adjustment but may reflect extreme limitations 
of self-reflective insight or reporting bias associated with particularly marked emotion processing 
problems. Ideally future studies using self-report measures should include the prospective collection 
of additional data (for instance physiological or implicit measures) to gain a better understanding of 
this issue.  
It would also be of interest, in future studies, to compare emotion processing deficits in patients 
with PNES with those seen in patients with epilepsy, i.e. an pathogenetically different seizure 
disorder. Ideally such a study would subdifferentiate between patients with different types of 
epilepsy and include additional measures to exploring the aetiology of emotion processing deficits 
(which is likely to be different in PNES and epilepsy). 
CONCLUSION 
In conclusion, this study shows clear differences in emotion processing as represented by the EPS 
scores between patients with PNES and healthy controls. Impaired emotion processing in patients 
with PNES correlates highly with emotional distress, a negative view of their illness, and a greater 
number and severity of physical symptoms in addition to their seizures. Whilst emotion-processing 
deficits were strongly associated with reduced mental health functioning, there was no correlation 
between the overall degree of self-reported emotion processing abnormalities and PNES frequency 
or physical functional impairment. The findings suggest that in most cases it is the over-control 
rather than lack of control of emotions that is associated with physical symptomatology. 
Whilst there are clear differences in EPS scores between patients with PNES and healthy controls 
and whilst the positive correlations with measures of distress and the negative correlations with the 
mental health component of the HRQoL measure used in this study support the face validity of the 
EPS as a measure in this patient group, this cross-sectional study cannot determine whether the EPS 
provides much additional information about patients with PNES. However, given that all recently 
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described psychotherapies for PNES specifically target emotion processing as an area for 
improvement [41], the EPS could provide a useful tool for the effectiveness of psychological 
intervention.  
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Figures 
 
Figure 1. Significant differences between the PNES and healthy control group in the median values of the total 
EPS scores and scores on the five EPS sub-scales (*differences are significant at p<0.001) 
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Tables 
 
Table 1. Correlation matrix of the EPS sub-scales in PNES 
    1 2 3 4 5 6 
1 Suppression       
2 Unprocessed Emotion .627*      
3 Unregulated Emotion .424* .733*     
4 Avoidance .588* .709* .681*    
5 
Impoverished Emotional 
Experience .693* .661* .562* .638*  
 
6 Total EPS .789* .853* .779* .819* .848*   
Note. * Correlation is significant at the 0.01 level. 
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Table 2. Median EPS scores in the different seizure frequency categories 
 Seizure Category P-values 
 More than 1 
seizure/month but less 
than 1 seizure/week 
M (IQR) 
More than 1 
seizure/week but 
less than 1 
seizure/day 
M (IQR) 
More than 1 
seizure/day but less 
than 1 seizure/hour 
M (IQR) 
 
N 15 15 12  
Suppression 7.2 (3.00) 5.80 (6.60) 7.30 (2.70) n.s. 
Unprocessed Emotion 6.4 (2.20) 5.00 (6.80) 6.70 (2.35) n.s. 
Unregulated Emotion 5.60 (2.60) 4.40 (5.00) 3.80 (1.45) .049 
Avoidance 6.40 (3.40) 4.80 (3.40) 6.20 (2.25) n.s. 
Impoverished 
Emotional Experience 
5.00 (3.00) 3.80 (5.40) 5.20 (3.40) n.s. 
Total EPS 6.12 (2.16) 4.32 (5.70) 6.20 (1.91) n.s. 
Note. M = median, IQR = interquartile range.  
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Table 3. Median values and interquartile ranges of the outcome measures including somatic symptom severity 
(PHQ-15), health-related quality of life (SF-36), psychological distress (CORE-10), illness perceptions (BIPQ) and 
seizure frequency in the PNES group. 
 
 
 
 
 
Note. N = number of subjects; M = median; IQR = interquartile range. Variation in sample sizes indicates missing data for 
certain variables.  
 
 
 
 
 
 
 
 
 
 
 
 
Outcome Measure N M IQR 
PHQ-15 50 13.00 11.25 
SF - 36    
   Physical Health Scale  49 31.98 15.99 
   Mental Health Scale 49 30.28 16.75 
CORE-10 48 20.50 14.50 
BIPQ 47 52.00 17.00 
Seizure Frequency (attacks/month) 45 8.00 27.25 
    16 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Correlation matrix showing the correlations between the compound EPS score and the other scales, 
including the PHQ-15, CORE-10, BIPQ, and the MHS and PHS summary sub-scales of the SF-36. 
  
 
 
 
 
 
 
 
 
 
 
Note. * Correlation is significant at the 0.01 level. 
 
 
 EPS PHQ-15 CORE-10 BIPQ SF-36 MHS SF-36 PHS 
EPS       
PHQ-15 .473*      
CORE-10 .723* .591*     
BIPQ .475* .582* .723*    
SF-36 MHS -.702* -.478* -.809* -.697*   
SF-36 PHS -0.088 -.476* -0.085 -.442* 0.031  
